Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
174M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
23.7M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$949M
-
Value change
-
+$61.1M
-
Number of buys
-
47
-
Number of sells
-
-30
-
Price
-
$40.10
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q1 2018
88 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q1 2018.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.7M shares
of 174M outstanding shares and own 13.57% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7.51M shares), Redmile Group, LLC (2.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.74M shares), EcoR1 Capital, LLC (1.46M shares), JANUS HENDERSON GROUP PLC (1.36M shares), Boxer Capital, LLC (1.35M shares), FMR LLC (977K shares), BB BIOTECH AG (896K shares), BlackRock Inc. (877K shares), and BRIDGER MANAGEMENT, LLC (519K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.